A haemodialysis system for the treatment of acute renal failure and metabolic disorders in neonates

2007 ◽  
Vol 29 (4) ◽  
pp. 516-524 ◽  
Author(s):  
N.L. Everdell
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure ◽  
Metabolic Disorders

scholarly journals Rhabdomyolysis-Induced Acute Renal Failure Following Fenofibrate Therapy: A Case Report and Literature Review

2010 ◽  
Vol 2010 ◽  
pp. 1-3 ◽  
Author(s):  
Ramazan Danis ◽  
Sami Akbulut ◽  
Sehmus Ozmen ◽  
Senay Arikan
Keyword(s):  
Skeletal Muscle ◽  
Renal Failure ◽  
Acute Renal Failure ◽  
Metabolic Disorders ◽  
Cell Damage ◽  
Pathological Condition ◽  
Skeletal Muscle Cell ◽  
Fibric Acid Derivative ◽  
Alcohol And Drug Use ◽  
Laboratory Examinations

Fenofibrate, a fibric acid derivative, is used to treat diabetic dyslipidemia, hypertriglyceridemia, and combined hyperlipidemia, administered alone or in combination with statins. Rhabdomyolysis is defined as a pathological condition involving skeletal muscle cell damage leading to the release of toxic intracellular material into circulation. Its major causes include muscle compression or overexertion; trauma; ischemia; toxins; cocaine, alcohol, and drug use; metabolic disorders; infections. However, rhabdomyolysis associated with fenofibrate is extremely rare. Herein we report a 45-year-old female patient who was referred to our department because of generalized muscle pain, fatigue, weakness, and oliguria over the preceding 3 weeks. On the basis of the pathogenesis and clinical and laboratory examinations, a diagnosis of acute renal failure secondary to fenofibrate-induced rhabdomyolysis was made. Weekly followups for patients who are administered fenofibrate are the most important way to prevent possible complications.

Pathophysiology of acute renal failure

1973 ◽  
Vol 131 (6) ◽  
pp. 911-928 ◽  
Author(s):  
W. Flamenbaum
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure
Sign in / Sign up

Export Citation Format

Share Document